4TISSUE
LIVE

Serial Number

79448423

Owner

4Tissue BV

Filing Date

Dec 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

4TISSUE Trademark

Serial Number: 79448423

4TISSUE is a trademark filed by 4Tissue BV on December 18, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

4Tissue BV (2 trademarks)

Technologiepark-Zwijnaarde 48

Entity Type: 26

Trademark Details

Filing Date

December 18, 2025

Registration Date

Not Registered

Goods & Services

Research, design and development in the field of biomaterials, regenerative medicine and drug delivery systems; medical research in the field of regenerative medicine and drug delivery systems; scientific studies in the field of biomaterials, regenerative medicine and drug delivery systems; testing and inspection services in the field of biomaterials, regenerative medicine and drug delivery systems; scientific laboratory services; scientific and medical research and development relating to products, technologies and treatments in the field of regenerative medicine and drug delivery systems for market approval through, among other things, clinical validation, regulatory approval and conducting clinical trials related thereto; culturing cells and tissues for scientific research purposes; synthesis (production) of biomaterials for scientific research purposes.

Medical services in the field of regenerative medicine and drug delivery systems; medical treatments, including injections, implants, oral, topical and external administrations, in the field of regenerative medicine and drug delivery systems; medical laboratory services; medical advice in the field of regenerative medicine and drug delivery systems; providing medical information in the field of regenerative medicine and drug delivery systems.

Medical preparations aimed at restoring the function of cells, tissues and organs; medical products, in particular hydrogels, gels, scaffolds [biological implants], matrices [biological tissue cultures] and tissue mimics, aimed at functional restoration of cells, tissues and organs; medical preparations and products that serve as carriers for drugs, cells and cell derivatives.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 2, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 1, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 28, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 27, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 23, 2026 REPR